MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
*Architects: Pulmonology (Health IT, Devices & Technology)
Biodesix, Inc. (NASDAQ:BDSX)*
Organization & Developments: Biodesix
VeriStrat™
Parents
Organization & Developments: Biodesix
Children
Blood test which is able to separate patients into groups with statistically different prognoses
It is the first mass spectrometry diagnostic that uses multiple markers and which has been shown to be clinically reproducible.
Such as gefitinib (Iressa, AstraZeneca) and erlotinib (Tarceva, OSI/Genentech/Roche).
When receiving second-line treatment using inhibitors to the epidermal growth factor receptor (EGFR)